BLUEWIND BIOTECHNOLOGY LIMITED
Executive Summary
BLUEWIND BIOTECHNOLOGY LIMITED currently exists as a dormant entity with no operational activity or financial transactions, maintaining a stable but minimal net asset base of £10,000. While there are no signs of financial distress, the lack of trading activity means the company is not generating income or cash flow, analogous to a patient in a medically induced coma. To improve financial health, the company should focus on activating operations, financial planning, and maintaining governance stability.
View Full Analysis Report →- Legal registered address
- Chase Business Centre 39-41 Chase Side London United Kingdom N14 5BP Copied!
Latest financial results as of 20 October 2025- Shareholders funds
- £10.00k
View full financial accounts- Shareholders funds
- £10.00k
- Company number
- 14717980 Copied!
Accounts
Latest annual accounts were to 31 March 2025
Next annual accounts are due by 31 December 2026
Company financial year end is on 31 March 2026
Confirmation statement
Latest confirmation statement statement dated 9 January 2025
Next statement due by 23 January 2026
Nature of business (SIC)
99999 - Dormant Company
Latest company documents
| Date | Description |
|---|---|
| 06/04/256 April 2025 | Accounts for a dormant company made up to 2025-03-31 |
| 31/03/2531 March 2025 | Annual accounts for year ending 31 Mar 2025 |
| 09/01/259 January 2025 | Termination of appointment of Haoxuan Wang as a director on 2025-01-09 |
| 09/01/259 January 2025 | Appointment of Mr Wei Lin as a director on 2025-01-09 |
| 09/01/259 January 2025 | Confirmation statement made on 2025-01-09 with updates |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company